Intensity Therapeutics, Inc. (INTS)
NASDAQ·Healthcare·Biotechnology
$3.74
+0.67%
Mkt Cap $14.65M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$125.00
Range $125.00 – $125.00
Implied Upside
+3246.7%
Consensus $125.00 vs current $3.74